2-85666719-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000542.5(SFTPB):​c.291G>A​(p.Glu97Glu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00295 in 1,613,860 control chromosomes in the GnomAD database, including 38 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0027 ( 5 hom., cov: 32)
Exomes 𝑓: 0.0030 ( 33 hom. )

Consequence

SFTPB
NM_000542.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: -0.123
Variant links:
Genes affected
SFTPB (HGNC:10801): (surfactant protein B) This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.79).
BP6
Variant 2-85666719-C-T is Benign according to our data. Variant chr2-85666719-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 165205.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.123 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.00274 (417/152180) while in subpopulation SAS AF= 0.00622 (30/4824). AF 95% confidence interval is 0.00448. There are 5 homozygotes in gnomad4. There are 197 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 5 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SFTPBNM_000542.5 linkuse as main transcriptc.291G>A p.Glu97Glu synonymous_variant 4/11 ENST00000519937.7 NP_000533.4 P07988D6W5L6

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SFTPBENST00000519937.7 linkuse as main transcriptc.291G>A p.Glu97Glu synonymous_variant 4/111 NM_000542.5 ENSP00000428719.2 P07988

Frequencies

GnomAD3 genomes
AF:
0.00275
AC:
418
AN:
152062
Hom.:
5
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000652
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00249
Gnomad ASJ
AF:
0.0245
Gnomad EAS
AF:
0.000193
Gnomad SAS
AF:
0.00601
Gnomad FIN
AF:
0.000471
Gnomad MID
AF:
0.0348
Gnomad NFE
AF:
0.00303
Gnomad OTH
AF:
0.00766
GnomAD3 exomes
AF:
0.00384
AC:
965
AN:
251296
Hom.:
10
AF XY:
0.00431
AC XY:
585
AN XY:
135832
show subpopulations
Gnomad AFR exome
AF:
0.000246
Gnomad AMR exome
AF:
0.00231
Gnomad ASJ exome
AF:
0.0185
Gnomad EAS exome
AF:
0.0000544
Gnomad SAS exome
AF:
0.00849
Gnomad FIN exome
AF:
0.000278
Gnomad NFE exome
AF:
0.00345
Gnomad OTH exome
AF:
0.00587
GnomAD4 exome
AF:
0.00297
AC:
4345
AN:
1461680
Hom.:
33
Cov.:
35
AF XY:
0.00322
AC XY:
2344
AN XY:
727170
show subpopulations
Gnomad4 AFR exome
AF:
0.00134
Gnomad4 AMR exome
AF:
0.00257
Gnomad4 ASJ exome
AF:
0.0177
Gnomad4 EAS exome
AF:
0.0000252
Gnomad4 SAS exome
AF:
0.00777
Gnomad4 FIN exome
AF:
0.000300
Gnomad4 NFE exome
AF:
0.00231
Gnomad4 OTH exome
AF:
0.00513
GnomAD4 genome
AF:
0.00274
AC:
417
AN:
152180
Hom.:
5
Cov.:
32
AF XY:
0.00265
AC XY:
197
AN XY:
74394
show subpopulations
Gnomad4 AFR
AF:
0.000650
Gnomad4 AMR
AF:
0.00248
Gnomad4 ASJ
AF:
0.0245
Gnomad4 EAS
AF:
0.000194
Gnomad4 SAS
AF:
0.00622
Gnomad4 FIN
AF:
0.000471
Gnomad4 NFE
AF:
0.00303
Gnomad4 OTH
AF:
0.00758
Alfa
AF:
0.00333
Hom.:
2
Bravo
AF:
0.00260
Asia WGS
AF:
0.00462
AC:
16
AN:
3478
EpiCase
AF:
0.00453
EpiControl
AF:
0.00468

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineFeb 21, 2013Glu109Glu in exon 5 of SFTPB: This variant is not expected to have clinical sign ificance because it does not alter an amino acid residue and is not located with in the splice consensus sequence. It has been identified in 0.3% (26/8600) of Eu ropean American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs34682912). -
Benign, criteria provided, single submitterclinical testingEurofins Ntd Llc (ga)Sep 21, 2016- -
not provided Benign:2
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpOct 22, 2023- -
Surfactant metabolism dysfunction, pulmonary, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Hereditary pulmonary alveolar proteinosis Benign:1
Benign, criteria provided, single submitterclinical testingAmbry GeneticsSep 09, 2020This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.79
CADD
Benign
1.8
DANN
Benign
0.47

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs34682912; hg19: chr2-85893842; API